Affordable Access

Publisher Website

PITUITARY FUNCTION IN PATIENTS RECEIVING INTERMITTENT CYTOTOXIC AND CORTICOSTEROID THERAPY FOR MALIGNANT LYMPHOMA

Authors
Journal
The Lancet
0140-6736
Publisher
Elsevier
Publication Date
Volume
307
Issue
7962
Identifiers
DOI: 10.1016/s0140-6736(76)93090-7
Disciplines
  • Medicine

Abstract

Abstract Diurnal variation in plasma-cortisol was studied immediately before and after intermittent steroid therapy in seven patients receiving monthly courses of quadruple chemotherapy for Hodgkin's or non-Hodgkin's lymphoma over a period of 6 months. The serum-thyroid-stimulating-hormone (T.S.H.) response to intravenous T.S.H.-releasing factor was also measured before and during the first course and before the second and fourth courses. The morning plasma-cortisol concentration fell significantly over 6 months when measured immediately before the start of each course. The mean evening cortisol concentration also fell over this period. In most patients the T.S.H. response showed a downward trend during treatment, although in two patients the response returned to normal whilst they were still undergoing therapy.

There are no comments yet on this publication. Be the first to share your thoughts.